Cite
Dipeptidyl peptidase-4 inhibitors for treatment of type 2 diabetes mellitus in the clinical setting: systematic review and meta-analysis.
MLA
Karagiannis, Thomas, et al. “Dipeptidyl Peptidase-4 Inhibitors for Treatment of Type 2 Diabetes Mellitus in the Clinical Setting: Systematic Review and Meta-Analysis.” BMJ (Clinical Research Ed.), vol. 344, Mar. 2012, p. e1369. EBSCOhost, https://doi.org/10.1136/bmj.e1369.
APA
Karagiannis, T., Paschos, P., Paletas, K., Matthews, D. R., & Tsapas, A. (2012). Dipeptidyl peptidase-4 inhibitors for treatment of type 2 diabetes mellitus in the clinical setting: systematic review and meta-analysis. BMJ (Clinical Research Ed.), 344, e1369. https://doi.org/10.1136/bmj.e1369
Chicago
Karagiannis, Thomas, Paschalis Paschos, Konstantinos Paletas, David R Matthews, and Apostolos Tsapas. 2012. “Dipeptidyl Peptidase-4 Inhibitors for Treatment of Type 2 Diabetes Mellitus in the Clinical Setting: Systematic Review and Meta-Analysis.” BMJ (Clinical Research Ed.) 344 (March): e1369. doi:10.1136/bmj.e1369.